NovaBridge Biosciences shares are trading higher. The company announced the appointment of Srishti Gupta as its CEO, effective July 1, succeeding Xi-Yong Fu.

Benzinga Newsdesk www.benzinga.com Neutral 88.2%

Neg 0% Neu 88.2% Pos 0%

Comments

No comments yet. Be the first!